Archive | Vaccine Science

RSS feed for this section

Herpes Vaccine Science

Therapeutic HSV-2 Vaccine: Critical Goal or Pipe Dream?

Therapeutic HSV-2 Vaccine: Critical Goal or Pipe Dream? To those who have followed my blog in the past, please accept my apology for about 7 months of radio silence. I took a Sabbatical Leave at the Rocky Mountain Laboratories (http://www.niaid.nih.gov/about/organization/dir/rml/Pages/default.aspx) from Dec 2013 to June 2014 to brush up on my techniques, and develop some […]

One-year anniversary

For those of you who follow this blog with some regularity, I thought a quick post was in order to acknowledge that this blog site is approaching its first anniversary; the first blog post was made on June 15, 2013.  By June 14, 2014, the Herpesvaccine Blog will have been visited over 116,000 times.  Thank […]

On the Agenus HerpV vaccine trials

Two readers recently asked me about the Agenus HerpV trials.  Given that this is a topic of broad concern to genital herpes sufferers, I have converted the original query and my response to a blog post as follows. – Bill H. ————————————— November 8, 2013 Dr. Halford, Agenus released their initial phase 2 results: http://www.antigenics.com/docs/press-releases/2013/herpv-vaccine-for-genital-herpes-meets-primary-endpoint.php […]

Halford HSV-2 Vaccine Research Highlights

Since setting up this blog in June 2013, I have received several inquiries about how my research fits into the broader topic of the field of HSV-2 vaccine research.  To address such questions in advance, I provide a brief summary below. For anyone interested in all the details, a quick visit to PubMed (http://www.ncbi.nlm.nih.gov/pubmed) followed […]